A round of seed financing brought in more than $1.5 million for Annapolis, Md.-based Vixiar Medical, which makes noninvasive devices for cardiopulmonary disease monitoring. The money will be used to finish regulatory submissions and support of final engineering and initial production for Indicor, the company's point-of-care device and digital platform designed to monitor worsening heart failure.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.